Machine learning and molecular validation reveal the PI3K/AKT/mTOR inflammatory axis for therapeutic targeting in severe COVID-19
Dysregulation of the PI3K/AKT/mTOR signaling axis contributes to COVID-19 severity by amplifying hyperinflammatory responses. This pilot study integrates molecular biology and explainable machine learning to characterize this pathway, emphasizing its negative regulator PTEN , in stratifying disease severity. RT-qPCR gene expression profiles from 83 laboratory-confirmed COVID-19 patients were merged with clinical data of lung involvement in three severity classes (mild: n = 40, moderate: n = 24, severe: n = 19). Molecular analysis revealed significant upregulation of IL-6 , PI3K , mTOR , and AKT1 in severe and fatal cases, alongside progressive downregulation of PTEN ( P < 0.001) and Cyclin D1 , suggesting impaired pathway inhibition and disrupted cell-cycle regulation. MMP-2 levels correlated with lung involvement. Eight machine learning classifiers were evaluated using Stratified 5-Fold Cross-Validation for multiclass severity stratification. Random Forest achieved the highest performance (Accuracy: 0.879 ± 0.041; F1-score: 0.874 ± 0.045; AUC-ROC: 0.978 ± 0.007), with robust per-class discrimination including the Severe class (F1: 0.727). Crucially, SHAP-based explainable AI independently validated the molecular findings by identifying PI3K (mean |SHAP| = 0.0984) as the most discriminative feature, followed by AKT1 (0.0838), IL-6 (0.0537), Cyclin D1 (0.0327), and PTEN (0.0287), confirming the canonical PI3K → Akt → mTOR signaling hierarchy. These findings demonstrate that integrating explainable AI with molecular validation can identify biologically coherent prognostic biomarkers, offering a transparent, hypothesis-generating framework for future targeted immunomodulatory research in severe SARS-CoV-2 infection.
Authors
- Hiva Alipanah (ORCID: https://orcid.org/0000-0002-0598-0912)
- Alireza Faghani Ghodrat (ORCID: https://orcid.org/0009-0008-3808-1674)
- Seyedeh-Samira Ashrafmansouri (ORCID: https://orcid.org/0000-0002-5089-4319)
- Sahar Samsami
- Ali Ghanbari Asad (ORCID: https://orcid.org/0000-0002-1725-1426)
- Mohammad Mehdi Naghizadeh (ORCID: https://orcid.org/0000-0001-5562-103X)
Institutions
- Shiraz University (IR)
- Fasa University of Medical Sciences (IR)
- Fasa University (IR)
- Iran University of Science and Technology (IR)
Publication Details
- Journal
- Scientific Reports
- Published
- 2026-11-19
- DOI
- https://doi.org/10.1038/s41598-026-80158-0
- Primary Topic
- COVID-19 Clinical Research Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00